Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Esas Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Esas Ventures

Esas Ventures

Operating

Esas Ventures: A Turkey-based venture capital firm investing in early-stage companies worldwide.

Location
Istanbul, Istanbul Province, TR
Founded
2018
Firm
Compare
Portfolio
Employees
Website

Investments

GoWit Technology
GoWit Technology

Total Raised

$1M

Rounds

1

Pre-Seed$1MJune 2023
River
River

Total Raised

$52.7M

Rounds

3

Series B$35MMay 2023
Flora
Flora

Total Raised

$9M

Rounds

3

Seed$9MSeptember 2022
Procol
Procol

Total Raised

$945.1M

Rounds

5

Series A$510MSeptember 2022
Moonvalley
Moonvalley

Total Raised

$36.4M

Rounds

5

Series Unknown$18.9MDecember 2021
Locale
Locale

Total Raised

$16.1M

Rounds

3

Seed$2MOctober 2021
Constrafor
Constrafor

Total Raised

$113.8M

Rounds

5

SeedJune 2021
Seer
Seer

Total Raised

$2.4M

Rounds

2

Seed$2.3MMarch 2021
Mayan
Mayan

Total Raised

$7M

Rounds

2

Seed$2MMarch 2021
Kunduz
Kunduz

Total Raised

$4.6M

Rounds

3

Seed$2.6MMarch 2021
DraftWise
DraftWise
Seed

Total Raised

$8M

Rounds

5

Seed$2.4MSeptember 2020
Lume
Lume

Total Raised

$1M

Rounds

1

Seed$1MAugust 2020
Alto Pharmacy
Alto Pharmacy
Acquired

Total Raised

$680M

Rounds

9

Series D$250MJanuary 2020
Series C$50MDecember 2018
Microverse
Microverse
Series A

Total Raised

$19.9M

Rounds

5

Seed$150kAugust 2019
Vitau
Vitau

Total Raised

$4.9M

Rounds

3

Seed$3MAugust 2019
Mipos.dev
Mipos.dev
Seed

Total Raised

$150k

Rounds

1

Seed$150kAugust 2019
Misfits Market
Misfits Market

Total Raised

$526.5M

Rounds

5

Series A$16.5MJune 2019
Deel
Deel

Total Raised

$979M

Rounds

10

Seed$3.9MApril 2019
Kalshi
Kalshi

Total Raised

$1B

Rounds

3

Pre-Seed$150kMarch 2019
Shield Bio
Shield Bio

Total Raised

$12.1M

Rounds

3

Series A$8MMay 2018
Biosplice Therapeutics
Biosplice Therapeutics

Total Raised

$778M

Rounds

5

SeedSeptember 2012